Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.88 USD | -3.23% | -8.04% | +307.18% |
08/05 | Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating | MT |
08/05 | Janux Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+307.18% | 2.35B | |
+64.21% | 62.59B | |
-1.73% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.75% | 26.21B | |
-21.75% | 19.09B | |
+4.42% | 13.08B | |
+25.58% | 12.26B | |
+28.42% | 12.05B |
- Stock Market
- Equities
- JANX Stock
- News Janux Therapeutics, Inc.
- Janux Therapeutics : Cowen Initiates Coverage on Janux Therapeutics With Outperform Rating